EP0785748A1 - Method and device for determining threshold values for energy metabolism - Google Patents
Method and device for determining threshold values for energy metabolismInfo
- Publication number
- EP0785748A1 EP0785748A1 EP95934163A EP95934163A EP0785748A1 EP 0785748 A1 EP0785748 A1 EP 0785748A1 EP 95934163 A EP95934163 A EP 95934163A EP 95934163 A EP95934163 A EP 95934163A EP 0785748 A1 EP0785748 A1 EP 0785748A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- testee
- pulse rate
- basis
- pulse
- energy metabolism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4866—Evaluating metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/22—Ergometry; Measuring muscular strength or the force of a muscular blow
- A61B5/221—Ergometry, e.g. by using bicycle type apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/22—Ergometry; Measuring muscular strength or the force of a muscular blow
- A61B5/221—Ergometry, e.g. by using bicycle type apparatus
- A61B5/222—Ergometry, e.g. by using bicycle type apparatus combined with detection or measurement of physiological parameters, e.g. heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/30—Input circuits therefor
- A61B5/301—Input circuits therefor providing electrical separation, e.g. by using isolating transformers or optocouplers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/30—Input circuits therefor
- A61B5/307—Input circuits therefor specially adapted for particular uses
- A61B5/308—Input circuits therefor specially adapted for particular uses for electrocardiography [ECG]
Definitions
- the invention relates to a method and a device for determining threshold values for energy metabolism, in which method a testee is subjected to a gradually increasing stress in order to obtain the threshold values for his energy metabolism.
- the lactic acid content of his blood first tends to drop below the original level. This is due to a faster circulation and the fact that the lactic acid elimination processing improves with muscle work. After this, if the speed of running is steadily increased, the lactic acid content begins to rise linearly with respect to the stress.
- the work rate at which the lactic acid content reaches its original value, and the corresponding levels of vital functions, such as pulse rate and oxygen consumption, are called an aerobic threshold.
- energy is produced aerobically, i.e. fats and carbohydrates are burned by means of oxygen.
- work rates exceeding the aerobic threshold energy is in turn produced to a greater and greater extent anaerobically, i.e.
- an aerobic threshold is thus defined as the stress level at which the lactic acid content in the blood of an athlete or a fitness enthusiast exceeds the level of rest, or at which the ventilation increases faster than previously with respect to the increasing stress.
- Pulse rate measurement can be utilized in estimating the work rate of an athlete or a fitness enthusiast, since the pulse rate and the work rate are linearly dependent on each other.
- An anaerobic threshold denotes the stress level at which the lactic acid content of blood starts rising rapidly and the ventilation begins to increase clearly faster than the stress or the oxygen consumption.
- Determining the aerobic and the anaerobic threshold is primarily used in the training of endurance athletes in order to determine a suitable training efficiency and to monitor the effects of the training. Similarly, for example the optimum training efficiency of a dieter can be determined by means of the thresholds.
- the aerobic and anaerobic threshold are nowadays determined in special test laboratories by means of a so-called maximum stress test. The test is started with a small stress. The stress is increased step by step every 2 to 3 minutes without any pauses up to the maximum level of performance. During the last 30 seconds of each stress, a blood sample is taken from the testee in order to determine the lactic acid level, or alternatively, the ventilation is measured.
- the threshold values determined by means of lactic acid and ventilation are usually very close to each other. The results are strongly influenced by the manner of stressing, the rate at which the stress is increased, and the stress levels used, wherefore different physical stress situations, such as a treadmill and an ergometer, provide different threshold values.
- Ventilation i.e. the respiratory volume per minute (VE) is obtained by multiplying the respiratory volume per time (TV) by the respiratory frequency (fr).
- Formula (1) shows that ventilation can be increased both by increasing the respiratory volume pei time and by increasing the respiratory frequency. They both change when the stress on the system increases.
- the respiratory volume per time is in most cases, but not always, almost linearly dependent on the stress level.
- the sharp increase in ventilation occurring after the anaerobic threshold is mainly due to the increase in the respiratory volume per time.
- a point of vertical intersection can almost always be seen in the respiratory frequency at the anaerobic threshold.
- the aerobic threshold of unfit testees cannot always be determined due to low aerobic strength and poor ability to process lactic acid.
- known methods and devices for determining threshold values for energy metabolism are based on difficult lactic acid and ventilation measurements wherein blood sampling and expensive laboratory equipment are central.
- the purpose of the present invention is to provide such a method and a device for determining threshold values for energy metabolism that are simple, reliable and require no trained medical personnel in order to be used.
- the method and the device according to the invention are characterized by what is disclosed in the claims below.
- the invention is based on the idea that signals provided by accurate pulse rate measurement contain information on the basis of which conclusions concerning the respiratory arrythmia can be drawn, the strength of the arrythmia depending both on the depth of respiration and the respiratory frequency. This in turn enables in principle the determination of the threshold values for energy metabolism on the basis of mere pulse rate measurement in the manner described above.
- the present pulse rate measuring devices that average the pulse rate do not provide sufficient accuracy.
- ECG electrocardiography
- the signal itself is called an ECG signal.
- Components resulting from the different functional periods of the heart can be distinguished from an ECG signal. These components are called P, Q, R, S, T and U waves (cf. Figure 1).
- a P wave is caused by the contraction of the atria.
- the ventricles are filled with blood.
- the most discernible feature of an ECG signal is its maximum, i.e.
- the R peak which has a shape that is determined by a so-called QRS complex formed by the peaks of three waves, and which develops when the ventricles contract.
- the right ventricle then pumps blood from the veins to the lungs and the left ventricle from the lungs to the arteries.
- the repolarization of the ventricular muscles causes a T wave, which is lower and more even than the R peak.
- the intervals between the waves depend on the rate at which a nervous impulse proceeds in the heart.
- the operation of the heart synchronizer i.e. the sinus, is not visible in an ECG signal.
- the ECG signal of a healthy person has the amplitude of 1 to 2 mV when measured from the surface of the skin.
- the R peak is given the amplitude value of 1.6 mV and the duration of 90 ms in the literature, whereas the corresponding values for the P wave are 0.25 nV and 110 ms.
- the durations and amplitudes of the different components in the ECG signal remain almost the same. It is therefore known that the exact measurement of the pulse rate and the related phenomena is possible by analysing the ECG signal of the pulse. As stated above, sufficient accuracy is not obtained, however, with the present wireless pulse rate measuring devices that average the pulse rate and that are mostly intended for sports and fitness.
- the easiest starting point for accurately determining the timing point of the ECG signal is the detection of the QRS complex.
- the QRS complex can be detected fairly simply with a peak detector.
- some kind of filtration is utilized in accurate analyses.
- bandpass filtration with which the frequencies contained in the QRS complex are accentuated, and in which the QRS complexes are separated from the filtered signal utilizing a non ⁇ linear interference rule based on a discernible property of the QRS complex, such as rate of rise, amplitude, etc. ;
- QRS complex is modelled for example in a FIR filter with filter coefficients, and cross-correlation with the incoming signal and the QRS correlation that is provided as coefficients is calculated;
- Pattern recognition aims at recognizing from the ECG signal the peaks resulting from the functional periods of the heart.
- the method is also applicable in the detection of timing points other than those based on the QRS complex.
- microprocessors enable the implementation of more and more complicated digital filter structures without any increase in the size and the current consumption of the device.
- the methods, shortly listed above, for recognizing timing points thus constitute only some of the feasible algorithms, and more methods are being developed continuously.
- Figure 2 shows a device according to the invention for determining threshold values for energy metabolism.
- Figure 3 shows a respiratory frequency, determined according to the invention on the basis of the variations in the intervals between the maximums of the ECG signal bursts of the pulse, as a function of the pulse level.
- Figure 1 shows a typical ECG signal caused by a pulse.
- the aforementioned P, Q, R, S, T and U waves can be recognized from each signal by means of accurate measurement.
- the peak value R represents the maximum of the ECG signal.
- the variations of the time intervals between these peaks i.e. the so-called R-R variation, are determined, and the respiratory frequency curve of the testee can be calculated on the basis of this variation as a function of the pulse rate.
- the pulse rate Due to the variation in the sympathetic- parasympathetic balance of the autonomic nervous system of humans, the pulse rate continuously fluctuates around the average pulse level.
- the sympathetic nervous system accelerates the pulse level and the parasympathetic nervous system slows it down.
- the fluctuation, i.e. variation, of the pulse rate results from the operation of the cardiovascular control system.
- the primary variations are respiratory arrhythmia, variation caused by a baroreflex, and variation resulting from the adjustment of the temperature balance of the system.
- the respiratory frequency Due to the attenuation caused by inhalation to the control of the vagus, the respiratory frequency is directly reflected in the pulse rate variation.
- Respiratory arrythmia has been found to be transmitted by the parasympathetic nervous system.
- the parasympathetic nervous system has been paralysed with suitable pharmaceuticals, whereupon the frequency component corresponding to respiration in the frequency spectrum of the pulse rate is considerably attenuated.
- the strength of the respiratory arrythmia depends both on the depth of respiration and the respiratory frequency.
- the maximum amplitude is obtained with the respiratory frequency of 5-7/minute, which is due to the fact that at this frequency the respiratory arrythmia and the pulse rate variation caused by the baroreflex arc intensify one another.
- the respiratory arrythmia is attenuated with the slope:
- the attenuation is individual, wherefore the values of respiratory arrhythmia at the respiratory frequencies of over 10/min are not mutually comparable.
- the respiratory frequency is kept constant and the volume of respiration is increased from 0.5 litres to 3.0 litres, the amplitude of respiratory arrythmia increases. The increase is linear up to 50 to 60% of the individual respiratory capacity with the slope:
- the parasympathetic tone first decreases gradually.
- the pulse rate reaches the level of about 100 beats/min, i.e. about 56% of the maximum pulse rate, the sympathetic activity starts increasing. Therefore, with a low stress the increase in the pulse rate is almost entirely due to the decreased parasympathetic activity.
- the sympathetic nervous system participates in the control of the pulse level together with the parasympathetic nervous system only at a higher stress level. However, the parasympathetic effect of the vagus decelerating the pulse remains during stress, even though it is greatly attenuated.
- the respiratory frequency can be determined from the intervals between the location points of the pulse ECG signal by calculating the first-degree subtractions, filtering the frequencies exceeding 1Hz from the obtained values, and by further calculating the respiration periods from the obtained graph during a certain time period, or by alternatively calculating the frequency spectrum of the filtered signal for example by means of Fourier transform, whereupon the respiratory frequency can be directly deduced from the resulting frequency response graph;
- FIG. 2 shows an example of the pulse rate measuring apparatus to be applied in the invention; the principle of the apparatus, but not its calculating efficiency and/or principle, corresponds to the telemetric pulse rate measuring device disclosed in Finnish Patent 68,734.
- the pulse rate measuring device thus preferably consists of a pulse transmitter to be attached to the chest of the testee, and of a receiver wirelessly receiving pulse signals and comprising the functions of pulse rate measurement and analysis.
- the equipment is formed, on the one hand, of a receiver A comprising an ECG preamplifier to which electrodes (not shown in the figures) identifying the pulse are connected.
- a signal from the preamplifier 1 is amplified in an AGC amplifier 2 and further in a power amplifier 3.
- the amplified signal is supplied to a transmission coil 4 that causes a magnetic field which is detected by a coil 5 of a receiver B forming the second part of the apparatus.
- the received signal is amplified similarly as in the transmitter by means of amplifier circuits 6 and 7.
- the amplified signal is supplied to a microprocessor 8 to which a memory 9 and a display unit 10 are connected.
- the pulse rate measuring device measures the pulse rate of the testee continuously throughout the performance.
- the measurement is performed without the averaging that reduces the accuracy.
- the microprocessor 8 of the pulse rate measuring device acts as an analyzer that differs from the previous averaging pulse rate measuring devices and that analyzes the ECG signal burst caused by each pulsation (cf. Figure 1) in order to determine the maximum R.
- the microprocessor 8 also performs the necessary mathematical examinations (cf. formulas 2 and 3) on the basis of the R-R variation in order to calculate the respiratory frequency curve of the testee as a function of the pulse rate during the performance. Finally, it determines the threshold values for the energy metabolism of the testee from the discontinuities of the respiratory frequency curve and shows them on the display unit 10.
- the discrimination ability of the pulse rate measuring device in the determination of the intervals between the maximums of successive ECG signal bursts is preferably at least around 1 ms.
- Figure 3 shows results of a test measuring, with the accuracy of 1 ms, the intervals between the maximums of the ECG signal bursts during the stress test of a testee, performed with an ergometer (stationary bicycle). Respiration events and the rate of their occurrence were determined from the obtained intervals with a mathematical method based on the above-described interdependencies of respiration and pulse rate.
- the graph of Figure 1 shows the discontinuity Kl of the respiratory frequency at the pulse rate of 140/min, which is the aerobic threshold of the testee.
- the anaerobic threshold K2 of the testee is at the pulse level of about 170/min.
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI944824 | 1994-10-13 | ||
FI944824A FI100377B (en) | 1994-10-13 | 1994-10-13 | Method and apparatus for determining energy metabolism thresholds |
PCT/FI1995/000565 WO1996011630A1 (en) | 1994-10-13 | 1995-10-11 | Method and device for determining threshold values for energy metabolism |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0785748A1 true EP0785748A1 (en) | 1997-07-30 |
EP0785748B1 EP0785748B1 (en) | 2003-05-07 |
Family
ID=8541585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95934163A Expired - Lifetime EP0785748B1 (en) | 1994-10-13 | 1995-10-11 | Method and device for determining threshold values for energy metabolism |
Country Status (5)
Country | Link |
---|---|
US (1) | US5810722A (en) |
EP (1) | EP0785748B1 (en) |
DE (1) | DE69530699T2 (en) |
FI (1) | FI100377B (en) |
WO (1) | WO1996011630A1 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69729768T2 (en) * | 1996-04-29 | 2005-07-14 | Pacesetter, Inc., Sylmar | Pacemaker with determination of the anaerobic threshold |
DE19752094C1 (en) * | 1997-11-25 | 1999-07-15 | Bundesrep Deutschland | Method for determining at least one piece of diagnostic information from signal patterns of medical sensor systems |
CN1162195C (en) | 1998-02-26 | 2004-08-18 | 欧姆龙株式会社 | Exercise machine, physical strength evaluating method, and pulsation meter |
WO2001028416A1 (en) | 1999-09-24 | 2001-04-26 | Healthetech, Inc. | Physiological monitor and associated computation, display and communication unit |
US6571200B1 (en) | 1999-10-08 | 2003-05-27 | Healthetech, Inc. | Monitoring caloric expenditure resulting from body activity |
CA2387124A1 (en) | 1999-10-08 | 2001-04-26 | Healthetech, Inc. | Integrated calorie management system |
US6736759B1 (en) | 1999-11-09 | 2004-05-18 | Paragon Solutions, Llc | Exercise monitoring system and methods |
US6600949B1 (en) * | 1999-11-10 | 2003-07-29 | Pacesetter, Inc. | Method for monitoring heart failure via respiratory patterns |
US7454002B1 (en) | 2000-01-03 | 2008-11-18 | Sportbrain, Inc. | Integrating personal data capturing functionality into a portable computing device and a wireless communication device |
FI115289B (en) * | 2000-02-23 | 2005-04-15 | Polar Electro Oy | Measurement of an organism's energy metabolism and glucose levels |
FI114201B (en) * | 2000-02-23 | 2004-09-15 | Polar Electro Oy | Estimation of lactate in the body |
FI114200B (en) | 2000-03-17 | 2004-09-15 | Polar Electro Oy | Determination of the stress level of an exercise performance |
US6482158B2 (en) | 2000-05-19 | 2002-11-19 | Healthetech, Inc. | System and method of ultrasonic mammography |
NL1015410C2 (en) * | 2000-06-09 | 2001-12-12 | Constance Dusirue Van Der Poel | Band placed about person's chest to monitor breathing rate and depth whilst exercising and hence determine fitness |
US6607387B2 (en) | 2000-10-30 | 2003-08-19 | Healthetech, Inc. | Sensor system for diagnosing dental conditions |
AU2002255568B8 (en) | 2001-02-20 | 2014-01-09 | Adidas Ag | Modular personal network systems and methods |
US20020147641A1 (en) * | 2001-04-04 | 2002-10-10 | Michele Hickford | Method and apparatus for rewarding behavior beneficial to health |
US20030208409A1 (en) * | 2001-04-30 | 2003-11-06 | Mault James R. | Method and apparatus for diet control |
TW555544B (en) * | 2001-05-28 | 2003-10-01 | Tonic Fitness Technology Inc | Method for measuring anaerobic threshold by detection and analysis of heartbeat data obtained during exercise |
AU2002330933A1 (en) * | 2001-08-03 | 2003-02-24 | Vega Research Lab, Llc | Method and apparatus for determining metabolic factors from an electrocardiogram |
DE10248500A1 (en) * | 2002-10-17 | 2004-05-19 | Hettich, Reinhard, Dr.med. | Anaerobic threshold determination method in which breathing rates are measured for successive periods and when the difference exceeds a predetermined threshold a signal is generated |
US20030126593A1 (en) * | 2002-11-04 | 2003-07-03 | Mault James R. | Interactive physiological monitoring system |
JP2007506158A (en) * | 2003-09-15 | 2007-03-15 | デビッド コヘン, | Emergency situation detection device |
US20050195079A1 (en) * | 2004-03-08 | 2005-09-08 | David Cohen | Emergency situation detector |
US7273453B2 (en) * | 2004-04-12 | 2007-09-25 | Frank Shallenberger | Method for analyzing the biological age of a subject |
US7161344B2 (en) * | 2004-04-20 | 2007-01-09 | International Business Machines Corporation | Method and structure for variable pitch microwave probe assembly |
US20070106132A1 (en) * | 2004-09-28 | 2007-05-10 | Elhag Sammy I | Monitoring device, method and system |
US20060079794A1 (en) * | 2004-09-28 | 2006-04-13 | Impact Sports Technologies, Inc. | Monitoring device, method and system |
US7887492B1 (en) | 2004-09-28 | 2011-02-15 | Impact Sports Technologies, Inc. | Monitoring device, method and system |
CA2632017C (en) | 2005-12-09 | 2014-02-25 | Swissrtec Gmbh | Stator for an impact crusher |
US20070142715A1 (en) * | 2005-12-20 | 2007-06-21 | Triage Wireless, Inc. | Chest strap for measuring vital signs |
US9779751B2 (en) | 2005-12-28 | 2017-10-03 | Breath Research, Inc. | Respiratory biofeedback devices, systems, and methods |
AU2006332837A1 (en) | 2005-12-28 | 2007-07-12 | Nirinjan Bikko | Breathing biofeedback device |
FI121214B (en) * | 2006-05-12 | 2010-08-31 | Suunto Oy | Procedure, apparatus and computer software for observing the physiological state of a person |
US7803117B2 (en) * | 2006-05-12 | 2010-09-28 | Suunto Oy | Method, device and computer program product for monitoring the physiological state of a person |
NL2000118C2 (en) * | 2006-06-30 | 2008-01-02 | R & S Techmedic B V | Method and analysis device for analyzing respiration. |
EP2469436B1 (en) * | 2006-11-01 | 2021-09-22 | ResMed Sensor Technologies Limited | System and method for monitoring cardiorespiratory parameters |
FI120619B (en) * | 2006-11-17 | 2009-12-31 | Suunto Oy | Device and method for monitoring performance |
US8292820B2 (en) * | 2006-11-17 | 2012-10-23 | Suunto Oy | Apparatus and device for performance monitoring |
US7666137B2 (en) * | 2008-04-10 | 2010-02-23 | Frank Shallenberger | Method for analyzing mitochondrial function |
FI124646B (en) | 2008-06-11 | 2014-11-28 | Suunto Oy | Connection and method of heart rate detection |
US20100185398A1 (en) * | 2009-01-22 | 2010-07-22 | Under Armour, Inc. | System and Method for Monitoring Athletic Performance |
US9433372B2 (en) * | 2010-12-23 | 2016-09-06 | Zephyr Technology Corporation | System method and device for providing an automated fitness test |
US10363453B2 (en) | 2011-02-07 | 2019-07-30 | New Balance Athletics, Inc. | Systems and methods for monitoring athletic and physiological performance |
US9642415B2 (en) | 2011-02-07 | 2017-05-09 | New Balance Athletics, Inc. | Systems and methods for monitoring athletic performance |
FI124973B (en) | 2011-02-17 | 2015-04-15 | Suunto Oy | Method and device for estimating energy consumption |
KR101333511B1 (en) | 2011-09-08 | 2013-11-28 | 연세대학교 산학협력단 | Novel Method to detect Ventilatory-threshold in real-time |
US9681836B2 (en) | 2012-04-23 | 2017-06-20 | Cyberonics, Inc. | Methods, systems and apparatuses for detecting seizure and non-seizure states |
US9814438B2 (en) | 2012-06-18 | 2017-11-14 | Breath Research, Inc. | Methods and apparatus for performing dynamic respiratory classification and tracking |
US10426426B2 (en) | 2012-06-18 | 2019-10-01 | Breathresearch, Inc. | Methods and apparatus for performing dynamic respiratory classification and tracking |
LU92104B1 (en) | 2012-11-28 | 2014-05-30 | Iee Sarl | Method and system for determining a ventilatory threshold |
US9192315B2 (en) | 2013-06-05 | 2015-11-24 | Siemens Medical Solutions Usa, Inc. | Patient signal analysis and characterization based on late potentials |
DE102013211908A1 (en) * | 2013-06-24 | 2014-12-24 | Adidas Ag | Apparatus and method for mobile determination of a physiological stress threshold |
US9277889B2 (en) | 2013-12-16 | 2016-03-08 | Siemens Medical Solutions Usa, Inc. | Patient signal analysis based on actiniform segmentation |
US20170113059A1 (en) * | 2014-04-11 | 2017-04-27 | Wristspace, Llc | Wrist worn sensor |
US9782092B2 (en) | 2014-11-14 | 2017-10-10 | Siemens Medical Solutions Usa, Inc. | Patient signal analysis based on vector analysis |
US11633152B2 (en) * | 2017-10-12 | 2023-04-25 | Purdue Research Foundation | Method of monitoring respiratory rate in a health monitoring device |
FR3122983A1 (en) | 2021-05-18 | 2022-11-25 | Age Impulse | Portable device allowing to characterize with precision and in a synthetic way the state of physical form of individuals in activity as well as to calculate and detect in real time and with precision their ventilatory thresholds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202350A (en) * | 1978-05-15 | 1980-05-13 | Walton Charles A | Device for measuring pulse, breathing and running rate for joggers |
GB1593839A (en) * | 1978-05-26 | 1981-07-22 | Pringle R D | Performance testing device |
US4566461A (en) * | 1983-02-15 | 1986-01-28 | Michael Lubell | Health fitness monitor |
FI68734C (en) * | 1983-11-11 | 1985-10-10 | Seppo Saeynaejaekangas | FOER FARAND FOR ORORDING FOR TELEMETRIC MAINTENANCE AV HANDLING FOR ECG SIGNAL WITH ANALYTICAL AV ETT MAGNETISKT NAERFAELT |
US4930518A (en) * | 1988-09-26 | 1990-06-05 | Hrushesky William J M | Sinus arrhythmia monitor |
GB9022623D0 (en) * | 1990-10-18 | 1990-11-28 | Univ Manchester | Depth of anaesthesia monitoring |
AT399449B (en) * | 1991-02-18 | 1995-05-26 | Helmut Dr Pfuetzner | Device for combined recording of heart and lung activity |
US5197489A (en) * | 1991-06-17 | 1993-03-30 | Precision Control Design, Inc. | Activity monitoring apparatus with configurable filters |
US5297558A (en) * | 1993-03-12 | 1994-03-29 | Medical Graphics Corporation | Algorithm for prescribing an exercise regimen to enhance fat burning and cardiovascular fitness |
US5456262A (en) * | 1993-11-01 | 1995-10-10 | Polar Electro Oy | Method for calculating a fitness index |
-
1994
- 1994-10-13 FI FI944824A patent/FI100377B/en active IP Right Grant
-
1995
- 1995-10-11 EP EP95934163A patent/EP0785748B1/en not_active Expired - Lifetime
- 1995-10-11 US US08/817,219 patent/US5810722A/en not_active Expired - Lifetime
- 1995-10-11 DE DE69530699T patent/DE69530699T2/en not_active Expired - Lifetime
- 1995-10-11 WO PCT/FI1995/000565 patent/WO1996011630A1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
See references of WO9611630A1 * |
Also Published As
Publication number | Publication date |
---|---|
US5810722A (en) | 1998-09-22 |
FI100377B (en) | 1997-11-28 |
FI944824A (en) | 1996-04-14 |
WO1996011630A1 (en) | 1996-04-25 |
FI944824A0 (en) | 1994-10-13 |
DE69530699D1 (en) | 2003-06-12 |
EP0785748B1 (en) | 2003-05-07 |
DE69530699T2 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5810722A (en) | Method and device for determining threshold values for energy metabolism | |
US6104947A (en) | Method and apparatus for determining exertion levels in fitness or athletic training and for determining the stress caused by training | |
EP1127542B1 (en) | Controlling of fitness exercise | |
EP2925217B1 (en) | Method and system for determining a ventilatory threshold | |
US5840039A (en) | Method and apparatus in connection with measuring the heartbeat rate of a person | |
US6584344B2 (en) | Method and apparatus for measuring heart rate | |
US7727159B2 (en) | Apparatus and method for detecting blood flow signal free from motion artifact and stress test apparatus using the same | |
US5738104A (en) | EKG based heart rate monitor | |
EP1273265B1 (en) | Monitoring a condition of a patient under anaesthesia or sedation | |
US20130009779A1 (en) | Method for determining the activity of the parasympathetic nervous system and/or the sympathetic nervous system of the autonomic nervous system of a living being | |
TWI272090B (en) | Devices and methods for heart-rate measurement and wrist-watch incorporating same | |
US20050124901A1 (en) | Method and apparatus for electrophysiological and hemodynamic real-time assessment of cardiovascular fitness of a user | |
US20100174205A1 (en) | Method, System and Software Product for the Measurement of Heart Rate Variability | |
CN108209902B (en) | Athlete competitive state evaluation method and system | |
CA2668400A1 (en) | System and method for monitoring cardiorespiratory parameters | |
EP0774234B1 (en) | Anesthetic depth detector | |
JPH09508293A (en) | Measurement and evaluation of electrical stability of the heart | |
US6616608B2 (en) | Periodic-physical-information measuring apparatus | |
KR20130134052A (en) | Apparatus for ppg signal processing | |
WO2004110241A2 (en) | Devices and methods for heart-rate measurement and wrist-watch incorporating same | |
EP4125570A1 (en) | A system and method for determining respiratory effort | |
Chen et al. | Improvement of oscillometric blood pressure estimates through suppression of breathing effects | |
Aarotale et al. | Potential of Weight Scale Based Ballistocardiography for Identifying Orthostatic Intolerance: A Tilt Table Study | |
Pu et al. | Comparison of R-wave detection errors of four wireless heart rate belts in the presence of noise | |
Tomchuk et al. | Methods and Algorithms for Processing Biomedical Signals in Assessing the Physiological Reserves of an Athlete |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970411 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB IT |
|
17Q | First examination report despatched |
Effective date: 20020111 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): DE FR GB IT |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69530699 Country of ref document: DE Date of ref document: 20030612 Kind code of ref document: P |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20040210 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20071020 Year of fee payment: 13 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081011 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20141031 Year of fee payment: 20 Ref country code: GB Payment date: 20141022 Year of fee payment: 20 Ref country code: DE Payment date: 20141024 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69530699 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20151010 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151010 |